Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
1.
Int J STD AIDS ; 24(3): 217-9, 2013 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-23535355

RESUMO

We estimated the burden of HIV-associated neurocognitive disorders (HAND) in a UK clinic. From a random sample, and referrals to specialist services over one year (neurology, clinical psychology, hospital admissions), we determined whether patients were diagnosed with HIV-associated dementia (HAD) and whether they reported symptoms suggesting neurocognitive impairment (NCI). In the first sample, 2/150 (prevalence 1.3%; 95% confidence interval [CI] 0.2-4.7%) had documented HAD. Eleven patients (7.3%; CI 3.7-12.7%) reported recent symptoms suggesting NCI; most of these individuals were diagnosed with a psychiatric or substance-use disorder. Among specialist referrals with symptoms suggesting NCI, 11 were diagnosed with HAD from a clinic population of 3129 individuals (annual incidence 0.4%; CI 0.2-0.6%). No patients with mildly symptomatic or asymptomatic HAND were identified in either sample, suggesting that such patients remain undetected in current clinical practice. Evidence-based screening for HAND in HIV clinics may be needed.


Assuntos
Complexo AIDS Demência/diagnóstico , Transtornos Cognitivos/complicações , Infecções por HIV/complicações , Complexo AIDS Demência/complicações , Complexo AIDS Demência/tratamento farmacológico , Complexo AIDS Demência/psicologia , Adulto , Idoso , Fármacos Anti-HIV/administração & dosagem , Fármacos Anti-HIV/uso terapêutico , Transtornos Cognitivos/epidemiologia , Transtornos Cognitivos/psicologia , Estudos Transversais , Feminino , Infecções por HIV/tratamento farmacológico , Infecções por HIV/epidemiologia , Humanos , Masculino , Pessoa de Meia-Idade , Testes Neuropsicológicos , Prevalência , Escalas de Graduação Psiquiátrica , Estudos Retrospectivos , Reino Unido/epidemiologia , Adulto Jovem
2.
HIV Med ; 11(2): 152-60, 2010 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-19732175

RESUMO

OBJECTIVES: Patients starting highly active antiretroviral therapy (HAART) may have a suboptimal CD4 increase despite rapid virological suppression. The frequency and the significance for patient care of this discordant response are uncertain. This study was designed to determine the incidence of a discordant response at two time-points, soon after 6 months and at 12 months, and to determine the relationship with clinical outcomes. METHODS: Data obtained in the UK Collaborative HIV Cohort Study were analysed. A total of 2584 treatment-naïve patients starting HAART with HIV viral load (VL) > 1000 HIV-1 RNA copies/mL at baseline and < 50 copies/mL within 6 months were included in the analysis. Patients were classified at either 6-10 (midpoint 8) months or 10-14 (midpoint 12) months as having a discordant (CD4 count increase < 100 cells/microL from baseline) or concordant response (CD4 count increase >or= 100 cells/microL). RESULTS: Discordant responses occurred in 32.1% of patients at 8 months and in 24.2% at 12 months; 35% of those discordant at 8 months were concordant at 12 months. A discordant response was associated with older age, lower baseline VL, and (at 12 months) higher baseline CD4 cell count. In a multivariate analysis it was associated with an increased risk of death, more strongly at 12 months [incidence rate ratio (IRR) 3.35, 95% confidence interval (CI) 1.73-6.47, P < 0.001] than at 8 months (IRR 2.08, 95% CI 1.19-3.64, P = 0.010), but not with new AIDS events. CONCLUSIONS: Discordant responders have a worse outcome, but assessment at 12 months may be preferred, given the number of 'slow' responders. Management strategies to improve outcomes for discordant responders need to be investigated.


Assuntos
Fármacos Anti-HIV/uso terapêutico , Terapia Antirretroviral de Alta Atividade , Infecções por HIV/tratamento farmacológico , Infecções por HIV/imunologia , HIV-1/efeitos dos fármacos , Síndrome da Imunodeficiência Adquirida/epidemiologia , Adulto , Contagem de Linfócito CD4 , Estudos de Coortes , Progressão da Doença , Feminino , Infecções por HIV/mortalidade , Humanos , Incidência , Modelos Logísticos , Masculino , Análise Multivariada , Fatores de Tempo , Resultado do Tratamento , Reino Unido , Carga Viral
3.
Sex Transm Infect ; 85(7): 514-9, 2009 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-19700413

RESUMO

OBJECTIVES: To compare the efficacy and safety of combination therapy with cryotherapy and podophyllotoxin 0.15% cream versus cryotherapy alone in the treatment of anogenital warts. METHODS: A randomised, double-blind, multicentre controlled trial. Patients received podophyllotoxin cream or placebo twice daily for 3 days/week for up to 4 weeks, with weekly cryotherapy continued to week 12 if required. Further treatment from week 12 to 24 was discretionary. Patients were stratified by sex and history of warts. HIV positivity, warts treated in the past 4 months, or warts with a combined area of less than 10 mm(2) were exclusion criteria. Primary endpoints were clearance at weeks 4 and 12. RESULTS: 70 patients per group were randomly assigned and started treatment; 101 first-episode warts, 91 male. No treatment-related serious adverse events were reported. Follow-up at week 12 was 85%. By intention-to-treat analysis, clearances at 4 and 12 weeks were higher in the combination group (60.0% and 60.0%, respectively) than with cryotherapy alone (45.7%, 45.7%) although not statistically significant (RR 1.31, 95% CI 0.95 to 1.81). By week 24 there was no difference between the groups (68.6% and 64.3%, respectively; RR 1.07, CI 0.84 to 1.35). At week 4, wart clearance was higher in men (p = 0.001) and those with a past history of warts (p = 0.009), but these differences were not detected at week 12. There was some evidence for a higher relapse rate in the group receiving cryotherapy alone. CONCLUSIONS: Initial combination therapy with podophyllotoxin/cryotherapy was well tolerated and may have resulted in earlier clearance in some patients, compared with cryotherapy alone; however, overall differences in clearance rates were not statistically significant.


Assuntos
Antivirais/administração & dosagem , Doenças do Ânus/tratamento farmacológico , Condiloma Acuminado/tratamento farmacológico , Crioterapia/métodos , Podofilotoxina/administração & dosagem , Doenças Urológicas/tratamento farmacológico , Adolescente , Adulto , Terapia Combinada , Método Duplo-Cego , Métodos Epidemiológicos , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Pomadas , Recidiva , Resultado do Tratamento , Adulto Jovem
4.
Int J STD AIDS ; 17(4): 277-9, 2006 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-16595053

RESUMO

Rectal gonorrhoea (GC) in men may cause anal discharge or proctitis, but these symptoms have been shown to correlate poorly with rectal infection. Culture of Neisseria gonorrhoeae from an exposed site offers a readily available, sensitive and cheap diagnostic test, and is currently the gold standard for diagnosis; however, these results can take a few days and therefore do not offer an instant diagnosis. Gram staining of rectal smears for N. gonorrhoeae has a low sensitivity but a high specificity when performed by experienced personnel. We audited whether rectal microscopy increased the number of patients diagnosed and treated for rectal GC at initial presentation at one inner London genitourinary clinic over a 12-month period. One hundred and thirty-six episodes of rectal GC were identified in 132 men. In all, 134/136 had rectal microscopy of whom, 47/134 (35%) were smear-positive for GC. Of the 136 cases, 90 received antibiotics for GC at their first presentation. Twenty-four of 90 (27%) would not have been treated until culture results were available, if rectal microscopy had not been performed. These results suggest that rectal microscopy remains an important tool and increases the proportion of men treated for GC at their first attendance.


Assuntos
Gonorreia/diagnóstico , Doenças Retais/diagnóstico , Adulto , Instituições de Assistência Ambulatorial , Gonorreia/epidemiologia , Gonorreia/patologia , Humanos , Londres/epidemiologia , Masculino , Auditoria Médica , Microscopia , Neisseria gonorrhoeae/isolamento & purificação , Valor Preditivo dos Testes , Doenças Retais/epidemiologia , Doenças Retais/patologia , Sensibilidade e Especificidade
5.
J Clin Virol ; 27(1): 52-8, 2003 May.
Artigo em Inglês | MEDLINE | ID: mdl-12727529

RESUMO

BACKGROUND: Laboratory-based study funded by the Research and Development Division of the Department of Health to inform the decision making on guidelines for the conduct of exposure prone procedures (EPPs) by health care workers who are hepatitis B carriers. OBJECTIVES: Define the quantity and nature of hepatitis B virus (HBV) DNA in hepatitis carriers whose serum does not contain hepatitis B e antigen (HBeAg) and in surgeons previously cleared to conduct EPPs who have transmitted HBV to their patients. STUDY DESIGN: Cross-sectional survey using HBV DNA quantification, genotyping and sequencing comparing transmitting surgeons and asymptomatic carriers. RESULTS: HBV DNA could be detected and quantified in 64.5% (136 of 211) of carriers whose serum did not contain HBeAg with a median level 3.6 log(10) copies/ml (range of 5.7 log(10) copies). Pre-core mutation appeared not to affect the HBV DNA level, however, all surgeons carried codon 28 variants and transmitted these variants to their patients. The lowest HBV DNA level in a transmitting surgeon was 4 x 10(4) copies/ml. CONCLUSIONS: Pre-core mutations are common in carriers whose serum does not contain HBeAg and do not specifically identify carriers whose HBV DNA levels are high. It was possible to define a level of virus above which transmission of hepatitis B during conduct of EPPs could not be excluded.


Assuntos
DNA Viral/sangue , Cirurgia Geral , Pessoal de Saúde , Vírus da Hepatite B/isolamento & purificação , Hepatite B/transmissão , Transmissão de Doença Infecciosa do Profissional para o Paciente , Portador Sadio/transmissão , Portador Sadio/virologia , Hepatite B/virologia , Antígenos E da Hepatite B/sangue , Vírus da Hepatite B/classificação , Vírus da Hepatite B/genética , Humanos
6.
Atherosclerosis ; 40(1): 75-80, Aug/Sep 1981.
Artigo em Inglês | MedCarib | ID: med-8595

RESUMO

Fasting serum lipoprotein lipid concentrations were measured in 64 subjects aged 11-18 and 72 aged 33-54 years, who comprised 86 percent of long-term residents of these ages in a rural community in Trinidad. Total HDL, HDL2 and HDL3 cholesterol concentration were similar in males and females after allowance for alcohol consumption. The results differ from other societies in which HDL2 concentration is lower in men than women,and are thought to provide further evidence for interaction between hormonal status and factors such as adiposity and tryglyceride concentration with respect to HDL concentration (AU)


Assuntos
Humanos , Criança , Adolescente , Adulto , Pessoa de Meia-Idade , Masculino , Feminino , Colesterol/análise , População Rural , Fatores Sexuais , Doença das Coronárias/etiologia , Dobras Cutâneas , HDL-Colesterol/análise , HDL-Colesterol/sangue , LDL-Colesterol/análise , LDL-Colesterol/sangue , VLDL-Colesterol/análise , VLDL-Colesterol/sangue , Consumo de Bebidas Alcoólicas
7.
Thorax ; 33(1): 85-8, Feb. 1978.
Artigo em Inglês | MedCarib | ID: med-10201

RESUMO

Prediction equations have been evolved for the assessment of vital capacity, total lung capacity, and the single breath carbon monoxide transfer factor in haemoglobin SS and haemoglobin SC disease. These relationships take account of the growth disorder and anaemia in the sickle-cell states. The results suggest that, in the clinically stable state, and effects of alveolar capillary sickling and haemoconcentration and any altered reactivity of haemoglobins S and C with the test gas are of no significance for clinical respiratory physiology. Sex differences in lung function appear independent of haemoglobin type. (AU)


Assuntos
Humanos , Adulto , Masculino , Feminino , Anemia Falciforme/fisiopatologia , Pulmão/fisiopatologia , Fatores Etários , Monóxido de Carbono , Hemoglobina C/análise , Doença da Hemoglobina C/fisiopatologia , Hemoglobina Falciforme/análise , Medidas de Volume Pulmonar , Fatores Sexuais
8.
Thorax ; 32(4): 486-96, Aug. 1977.
Artigo em Inglês | MedCarib | ID: med-12707

RESUMO

The relationships of forced expiratory volume and forced vital capacity of height, age, sex, area of residence, and ethnic composition were assessed in 622 children in Jamaica. Rural children in hill-farming communities were judged to have a higher habitual physical activity than urban children. Allowing for differences in body size, forced vital capacity averaged 3 percent greater in rural children than in urban children, 7 percent less in girls than in boys, and 16 percent greater in children of European origin than in children of African descent. Lung volumes, indices of gas transfer, and sub-maximal-exercise responses were measured in a subgroup of 108 children of African descent believed to be of common genetic stock. Total lung capacity and vital capacity averaged respectively 6 percent greater and 7 percent greater in rural than in urban children of equal height but residual volume and transfer factor did not differ significantly between localities. Rural children had a lower average cardiac and respiratory components of the oxygen transport system, consonant with the demand for muscular work. Increased habitual physical capacity, total lung capacity, and transfer factor (AU)


Assuntos
Humanos , Criança , Adolescente , Masculino , Feminino , Pulmão/fisiologia , Etnicidade , Aptidão Física , Esforço Físico , Fluxo Expiratório Forçado , Volume Expiratório Forçado , Capacidade Vital , Jamaica
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...